000 | 03933nam a22005175i 4500 | ||
---|---|---|---|
001 | 978-1-60327-079-3 | ||
003 | DE-He213 | ||
005 | 20161121230842.0 | ||
007 | cr nn 008mamaa | ||
008 | 100301s2008 xxu| s |||| 0|eng d | ||
020 |
_a9781603270793 _9978-1-60327-079-3 |
||
024 | 7 |
_a10.1007/978-1-60327-079-3 _2doi |
|
050 | 4 | _aRC870-923.2 | |
050 | 4 | _aRC875-899.5 | |
072 | 7 |
_aMJS _2bicssc |
|
072 | 7 |
_aMED088000 _2bisacsh |
|
082 | 0 | 4 |
_a616.6 _223 |
245 | 1 | 0 |
_aProstate Cancer _h[electronic resource] : _bSignaling Networks, Genetics, and New Treatment Strategies / _cedited by Richard G. Pestell, Marja T. Nevalainen, Michael Milken. |
264 | 1 |
_aTotowa, NJ : _bHumana Press, _c2008. |
|
300 |
_aXVI, 456 p. 33 illus., 11 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 | _aCurrent Clinical Oncology | |
505 | 0 | _aHistopathology and Molecular Biology of Prostate Atrophy -- Epigenetic Gene Silencing in Prostate Cancer -- Inherited Genetic Changes in Prostate Cancer -- Prostate Molecular Oncogenesis -- Somatic Genetic Changes in Prostate Cancer -- Androgen Receptor in Prostate Cancer Progression -- Epigenetic Modification and Acetylation of Androgen Receptor Regulate Prostate Cellular Growth -- Estrogen Receptor ? and ? in the Regulation of Normal and Malignant Prostate Epithelium -- Estrogen Action in Normal Prostate Epithelium and in Prostate Cancer -- Hypoxia-Inducible Factor 1 in the Angiogenesis of Prostate Cancer -- Signal Transduction by the Ras–MAP Kinase Pathway in Prostate Cancer Progression -- Transcription Factors STAT5 and STAT3 -- Role of PI3K–Akt and PTEN in the Growth and Progression of Prostate Cancer -- New Perspectives in Prediction of Clinical Outcome of Prostate Cancer -- New Directions in Radiation Therapy of Prostate Cancer -- The Current Knowledge of Hormonal Therapy in the Treatment of Prostate Cancer -- Advances in Surgical Intervention of Prostate Cancer -- Targeted Therapy Trials for Prostate Cancer -- New Perspectives on Chemotherapy in Prostate Cancer -- Concluding Remarks. | |
520 | _aAward winning authors present a comprehensive review of new perspectives in prostate cancer research and open up new directions in the clinical management of prostate cancer. In, "Prostate Cancer: Signaling Networks, Genetics, and New Treatment Strategies", the authors focus on the biology, genetics, molecular signaling networks in the disease process, and recent advances in the treatment of prostate cancer. This state-of-the-art title provides key insights into cutting edge advances in prostate cancer research, such as laparoscopic radical prostatectomy, and offers a critical evaluation and discussion of opportunities for development of novel therapies for prostate cancer. Clinical trials that have not been covered or evaluated in any other books currently available are also discussed. Invaluable to physicians and researchers, "Prostate Cancer: Signaling Networks, Genetics, and New Treatment Strategies" provides a comprehensive translational resource as well as an important source of information for prostate cancer patients. | ||
650 | 0 | _aMedicine. | |
650 | 0 | _aInternal medicine. | |
650 | 0 | _aOncology. | |
650 | 0 | _aUrology. | |
650 | 1 | 4 | _aMedicine & Public Health. |
650 | 2 | 4 | _aUrology. |
650 | 2 | 4 | _aOncology. |
650 | 2 | 4 | _aInternal Medicine. |
700 | 1 |
_aPestell, Richard G. _eeditor. |
|
700 | 1 |
_aNevalainen, Marja T. _eeditor. |
|
700 | 1 |
_aMilken, Michael. _eeditor. |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9781588297419 |
830 | 0 | _aCurrent Clinical Oncology | |
856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-1-60327-079-3 |
912 | _aZDB-2-SME | ||
950 | _aMedicine (Springer-11650) | ||
999 |
_c504924 _d504924 |